Top Markets
Coin of the day
ReShape Lifesciences Inc. ReShape Lifesciences Inc.

ReShape Lifesciences Inc.

RSLS
Rang in aandelen #36770
Founded in 2002 and based in San Clemente, California, ReShape Lifesciences... Founded in 2002 and based in San Clemente, California, ReShape Lifesciences Inc. operates as a medical device company dedicated to addressing obesity and metabolic diseases. The company's market extends throughout the United States, Australia, Europe, and globally. Its diverse product lineup features the Lap-Band System, a minimally invasive, long-term solution for severe obesity that offers an alternative to more extensive surgical interventions like gastric bypass or sleeve gastrectomy. Under development is the ReShape Vest system, an investigational, minimally invasive device that is laparoscopically implanted around the stomach to assist obese and morbidly obese patients in losing weight, without cutting or permanently removing parts of the stomach or bypassing any section of the gastrointestinal tract. ReShape also supports patients through the ReShapeCare virtual health coaching program, a telehealth service aimed at promoting healthy lifestyle adjustments for individuals undergoing medically supervised weight management. Additionally, the company is conducting preclinical development for ReShape Diabetes Bloc-Stim Neuromodulation, a technology intended for the treatment of type 2 diabetes mellitus. Among its offerings is the Obalon Balloon System, a swallowable capsule used to monitor and display the balloon's exact position during its placement. The company, initially incorporated as EnteroMedics Inc., changed its name to ReShape Lifesciences Inc. in 2017.
Aandeelprijs
$3.92
Laatst gesynchroniseerd: 2025-08-14
Marktkapitalisatie
$2.34M
Verandering (1 dag)
-69.38%
Verandering (1 jaar)
0.00%
Land
US
Handel ReShape Lifesciences Inc. (RSLS)

Categorie

Prijs RSLS met de marktkapitalisatie van B
ReShape Lifesciences Inc. ReShape Lifesciences Inc.
RSLS
$3.92
Marktkapitalisatie van ReShape Lifesciences Inc.(RSLS)
Marktkapitalisatie: $2.34M
Vanaf August 2026 heeft ReShape Lifesciences Inc. een marktkapitalisatie van $2.34M. Dit maakt ReShape Lifesciences Inc. volgens onze gegevens het 36770th meest waardevolle bedrijf ter wereld op basis van marktkapitalisatie. De marktkapitalisatie is de totale marktwaarde van alle uitstaande aandelen van een beursgenoteerd bedrijf en wordt vaak gebruikt om de waarde van een bedrijf te meten.
Marktkapitalisatiegeschiedenis van ReShape Lifesciences Inc. van 2019 tot 2026
RSLS vergeleken met de top 5 populairste stocks
Prijs voor RSLS Aandeel B Marktkapitalisatie van B uitslagen
ReShape Lifesciences Inc. ReShape Lifesciences Inc.
$9,139,571 $2.34M
$5.452T +233,152,220.33%
ReShape Lifesciences Inc. ReShape Lifesciences Inc.
$7,527,119 $2.34M
$4.490T +192,018,245.26%
ReShape Lifesciences Inc. ReShape Lifesciences Inc.
$6,977,905 $2.34M
$4.162T +178,007,676.79%
ReShape Lifesciences Inc. ReShape Lifesciences Inc.
$6,163,061 $2.34M
$3.676T +157,220,840.04%
ReShape Lifesciences Inc. ReShape Lifesciences Inc.
$4,749,344 $2.34M
$2.833T +121,156,629.05%